Cough (acute · subacute · chronic)
Protocol · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Classify by duration: acute <3 wk (viral), subacute 3–8 wk (post-infectious), chronic >8 wk (UACS/asthma/GERD/eosinophilic bronchitis/COPD).
Assessment
Investigations
- SpO₂; CXR for any chronic cough, smoker, haemoptysis, focal signs or weight loss
- Acute: FBC/CRP, CURB-65 (pneumonia), D-dimer/CTPA (PE)
- Chronic: spirometry ± bronchoprovocation (often false+; confirm by response to Rx); sputum/TB if at risk
Management
- Treat pneumonia/sepsis; foreign body (choking + focal wheeze) → bronchoscopy
- Chronic — empiric trials + review: nasal steroid/antihistamine (UACS), inhaled steroid (asthma/eosinophilic bronchitis), antireflux (GERD), STOP ACE inhibitor (dry cough, resolves in days–weeks)
- Reflux/UACS often silent (no heartburn/postnasal symptoms in >40%)
Disposition
Post-infectious subacute cough self-limits. Red flags — haemoptysis, weight loss, night sweats, new/changed smoker’s cough, cough >1 month after quitting → urgent CXR + 2-week-wait respiratory referral (lung cancer/TB).
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.